Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
The authors examine the interface between for-profit and publicly funded pharmaceuticals. Firms access upstream basic research through investments in absorptive capacity in the form of in-house basic research and 'propublication' internal incentives. Some firms also maintain extensive connections to the wider scientific community, which they measure using data on coauthorship of scientific papers between pharmaceutical company scientists and publicly funded researchers. 'Connectedness' is significantly correlated with firms' internal organization, as well as their performance in drug discovery. The estimated impact of connectedness on private research productivity implies a substantial return to public investments in basic research. Copyright 1998 by Blackwell Publishing Ltd
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 46 (1998)
Issue (Month): 2 (June)
|Contact details of provider:|| Web page: http://www.blackwellpublishing.com/journal.asp?ref=0022-1821|
|Order Information:||Web: http://www.blackwellpublishing.com/subs.asp?ref=0022-1821|
When requesting a correction, please mention this item's handle: RePEc:bla:jindec:v:46:y:1998:i:2:p:157-82. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Wiley-Blackwell Digital Licensing)or (Christopher F. Baum)
If references are entirely missing, you can add them using this form.